advanced cell technology inc
(ACTC:OTC BB)
Executive Profile*
Gary H. RabinChairman of The Board, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer and Member of Nominating & Corporate Governance Committee, Advanced Cell Technology Inc. |
| Age | Total Calculated Compensation | This person is connected to 10 board members in 1 different organizations across 1 different industries. See Board Relationships |
| 47 | $840,000 As of Fiscal Year 2012 |
Background*
Mr. Gary H. Rabin has been the Chairman of the Board and Chief Executive Officer of Advanced Cell Technology Inc. since December 2010. Mr. Rabin serves as Managing Partner of Vine Holdings. Mr. Rabin served as an Interim Chairman and Interim Chief Executive Officer of Advanced Cell Technology Inc. Mr. Rabin served as a Portfolio Manager of MAC Investment Management, LLC ("MAC") until July 2007, which he joined in November 2005. Mr. Rabin Founded ING Barings Furman Selz ...
Corporate Headquarters*33 Locke DriveMarlborough, Massachusetts 01752 United States Phone: 508-756-1212 Fax: 508-229-2333 Board Members Memberships*2007-Present Chairman of The Board, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer and Member of Nominating & Corporate Governance Committee
Education*BA University of Michigan
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| ACTC:US | $0.07 USD | -0.0002 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Michael D. West Ph.D. | Chief Executive officer, President and Director BioTime, Inc. | $760.5K |
| John A. Scarlett M.D. | Chief Executive Officer, President and Director Geron Corporation | $589.6K |
| Christopher J. Calhoun | Co-Founder, Vice Chairman, Chief Executive Officer, Secretary and Member of Executive Committee Cytori Therapeutics, Inc. | $467.9K |
| Martin M. McGlynn | Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc StemCells Inc. | $752.1K |
| Robin L. Smith M.D., MBA,Ro | Executive Chairman and Chief Executive Officer Neostem, Inc. | $775.7K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact ADVANCED CELL TECHNOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
